| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Vitiligo | 19 | 0 | |
| Eczema | 11 | 2 | |
| Atopic dermatitis | 4 | 2 | |
| Butterfly (malar) rash | 2 | 1 | |
| Inflammation | 2 | 2 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 1 | |
| None | 7 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Vitiligo | 19 | 0 | |
| Eczema | 11 | 2 | |
| Atopic dermatitis | 4 | 2 | |
| Butterfly (malar) rash | 2 | 1 | |
| Inflammation | 2 | 2 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 1 | |
| None | 7 |